{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T06:55:39Z","timestamp":1771656939399,"version":"3.50.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1007\/s00262-011-1121-4","type":"journal-article","created":{"date-parts":[[2011,10,14]],"date-time":"2011-10-14T16:01:08Z","timestamp":1318608068000},"page":"535-547","source":"Crossref","is-referenced-by-count":50,"title":["Mycobacteria activate \u03b3\u03b4 T-cell anti-tumour responses via cytokines from type 1 myeloid dendritic cells: a mechanism of action for cancer immunotherapy"],"prefix":"10.1007","volume":"61","author":[{"given":"Daniel W.","family":"Fowler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Copier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalie","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angus G.","family":"Dalgleish","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark D.","family":"Bodman-Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,10,15]]},"reference":[{"issue":"1","key":"1121_CR1","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.juro.2007.08.122","volume":"179","author":"HW Herr","year":"2008","unstructured":"Herr HW, Morales A (2008) History of bacillus Calmette-Guerin and bladder cancer: an immunotherapy success story. J Urol 179(1):53\u201356","journal-title":"J Urol"},{"issue":"7","key":"1121_CR2","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1023\/A:1008307821189","volume":"10","author":"A Maraveyas","year":"1999","unstructured":"Maraveyas A, Baban B, Kennard D, Rook GA, Westby M, Grange JM, Lydyard P, Stanford JL, Jones M, Selby P, Dalgleish AG (1999) Possible improved survival of patients with stage IV AJCC melanoma receiving SRL 172 immunotherapy: correlation with induction of increased levels of intracellular interleukin-2 in peripheral blood lymphocytes. Ann Oncol 10(7):817\u2013824","journal-title":"Ann Oncol"},{"issue":"7","key":"1121_CR3","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1054\/bjoc.2000.1401","volume":"83","author":"ME O\u2019Brien","year":"2000","unstructured":"O\u2019Brien ME, Saini A, Smith IE, Webb A, Gregory K, Mendes R, Ryan C, Priest K, Bromelow KV, Palmer RD, Tuckwell N, Kennard DA, Souberbielle BE (2000) A randomized phase II study of SRL172 (Mycobacterium vaccae) combined with chemotherapy in patients with advanced inoperable non-small-cell lung cancer and mesothelioma. Br J Cancer 83(7):853\u2013857","journal-title":"Br J Cancer"},{"issue":"1","key":"1121_CR4","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1046\/j.1464-410X.2002.02572.x","volume":"89","author":"JD Eaton","year":"2002","unstructured":"Eaton JD, Perry MJ, Nicholson S, Guckian M, Russell N, Whelan M, Kirby RS (2002) Allogeneic whole-cell vaccine: a phase I\/II study in men with hormone-refractory prostate cancer. BJU Int 89(1):19\u201326","journal-title":"BJU Int"},{"issue":"2","key":"1121_CR5","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ejca.2007.11.003","volume":"44","author":"PM Patel","year":"2008","unstructured":"Patel PM, Sim S, O\u2019Donnell DO, Protheroe A, Beirne D, Stanley A, Tourani JM, Khayat D, Hancock B, Vasey P, Dalgleish A, Johnston C, Banks RE, Selby PJ (2008) An evaluation of a preparation of Mycobacterium vaccae (SRL172) as an immunotherapeutic agent in renal cancer. Eur J Cancer 44(2):216\u2013223","journal-title":"Eur J Cancer"},{"issue":"6","key":"1121_CR6","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1093\/annonc\/mdh220","volume":"15","author":"ME O\u2019Brien","year":"2004","unstructured":"O\u2019Brien ME, Anderson H, Kaukel E, O\u2019Byrne K, Pawlicki M, Von Pawel J, Reck M, SR-ON-12 Study Group (2004) SRL172 (killed Mycobacterium vaccae) in addition to standard chemotherapy improves quality of life without affecting survival, in patients with advanced non-small-cell lung cancer: phase III results. Ann Oncol 15(6):906\u2013914","journal-title":"Ann Oncol"},{"issue":"2","key":"1121_CR7","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.ejca.2007.08.021","volume":"44","author":"JL Stanford","year":"2008","unstructured":"Stanford JL, Stanford CA, O\u2019Brien ME, Grange JM (2008) Successful immunotherapy with Mycobacterium vaccae in the treatment of adenocarcinoma of the lung. Eur J Cancer 44(2):224\u2013227","journal-title":"Eur J Cancer"},{"key":"1121_CR1000","doi-asserted-by":"crossref","unstructured":"Stebbing J, Dalgleish A, Gifford-Moore A, Martin A, Gleeson C, Wilson G, Brunet LR, Grange J, Mudan S (2011) An intra-patient placebo-controlled phase I trial to evaluate the safety and tolerability of intradermal IMM-101 in melanoma. Ann Oncol. doi: 10.1093\/annonc\/mdr363","DOI":"10.1093\/annonc\/mdr363"},{"issue":"9","key":"1121_CR8","doi-asserted-by":"crossref","first-page":"6044","DOI":"10.4049\/jimmunol.180.9.6044","volume":"180","author":"Z Liu","year":"2008","unstructured":"Liu Z, Eltoum IE, Guo B, Beck BH, Cloud GA, Lopez RD (2008) Protective immunosurveillance and therapeutic antitumor activity of gammadelta T cells demonstrated in a mouse model of prostate cancer. J Immunol 180(9):6044\u20136053","journal-title":"J Immunol"},{"issue":"3","key":"1121_CR9","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1084\/jem.20030584","volume":"198","author":"Y Gao","year":"2003","unstructured":"Gao Y, Yang W, Pan M, Scully E, Girardi M, Augenlicht LH, Craft J, Yin Z (2003) Gamma delta T cells provide an early source of interferon gamma in tumor immunity. J Exp Med 198(3):433\u2013442","journal-title":"J Exp Med"},{"issue":"5542","key":"1121_CR10","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1126\/science.1063916","volume":"294","author":"M Girardi","year":"2001","unstructured":"Girardi M, Oppenheim DE, Steele CR, Lewis JM, Glusac E, Filler R, Hobby P, Sutton B, Tigelaar RE, Hayday AC (2001) Regulation of cutaneous malignancy by gammadelta T cells. Science 294(5542):605\u2013609","journal-title":"Science"},{"key":"1121_CR11","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1600-065X.2006.00479.x","volume":"215","author":"CT Morita","year":"2007","unstructured":"Morita CT, Jin C, Sarikonda G, Wang H (2007) Nonpeptide antigens, presentation mechanisms, and immunological memory of human Vgamma2Vdelta2 T cells: discriminating friend from foe through the recognition of prenyl pyrophosphate antigens. Immunol Rev 215:59\u201376","journal-title":"Immunol Rev"},{"issue":"3","key":"1121_CR12","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1365-3083.1993.tb01720.x","volume":"38","author":"MH Wang","year":"1993","unstructured":"Wang MH, Chen YQ, Gercken J, Ernst M, B\u00f6hle A, Flad HD, Ulmer AJ (1993) Specific activation of human peripheral blood gamma\/delta + lymphocytes by sonicated antigens of Mycobacterium tuberculosis: role in vitro in killing human bladder carcinoma cell lines. Scand J Immunol 38(3):239\u2013246","journal-title":"Scand J Immunol"},{"issue":"2\u20133","key":"1121_CR13","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1365-3083.2007.01963.x","volume":"66","author":"P Wrobel","year":"2007","unstructured":"Wrobel P, Shojaei H, Schittek B, Gieseler F, Wollenberg B, Kalthoff H, Kabelitz D, Wesch D (2007) Lysis of a broad range of epithelial tumour cells by human gamma delta T cells: involvement of NKG2D ligands and T-cell receptor- versus NKG2D-dependent recognition. Scand J Immunol 66(2\u20133):320\u2013328","journal-title":"Scand J Immunol"},{"issue":"8","key":"1121_CR14","doi-asserted-by":"crossref","first-page":"3932","DOI":"10.4049\/jimmunol.154.8.3932","volume":"154","author":"A Choudhary","year":"1995","unstructured":"Choudhary A, Davodeau F, Moreau A, Peyrat MA, Bonneville M, Jotereau F (1995) Selective lysis of autologous tumor cells by recurrent gamma delta tumor-infiltrating lymphocytes from renal carcinoma. J Immunol 154(8):3932\u20133940","journal-title":"J Immunol"},{"issue":"4","key":"1121_CR15","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s00262-007-0391-3","volume":"57","author":"F Bouet-Toussaint","year":"2008","unstructured":"Bouet-Toussaint F, Cabillic F, Toutirais O, Le Gallo M, Thomas de la Pinti\u00e8re C, Daniel P, Genetet N, Meunier B, Dupont-Bierre E, Boudjema K, Catros V (2008) Vgamma9\u00a0Vdelta2 T cell-mediated recognition of human solid tumors. Potential for immunotherapy of hepatocellular and colorectal carcinomas. Cancer Immunol Immunother 57(4):531\u2013539","journal-title":"Cancer Immunol Immunother"},{"issue":"4","key":"1121_CR16","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1128\/CMR.9.4.532","volume":"9","author":"DR Lucey","year":"1996","unstructured":"Lucey DR, Clerici M, Shearer GM (1996) Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases. Clin Microbiol Rev 9(4):532\u2013562","journal-title":"Clin Microbiol Rev"},{"issue":"5563","key":"1121_CR17","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1126\/science.1068819","volume":"295","author":"Y Shen","year":"2002","unstructured":"Shen Y, Zhou D, Qiu L, Lai X, Simon M, Shen L, Kou Z, Wang Q, Jiang L, Estep J, Hunt R, Clagett M, Sehgal PK, Li Y, Zeng X, Morita CT, Brenner MB, Letvin NL, Chen ZW (2002) Adaptive immune response of Vgamma2Vdelta2+ T cells during mycobacterial infections. Science 295(5563):2255\u20132258","journal-title":"Science"},{"issue":"10","key":"1121_CR18","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1007\/s00262-010-0893-2","volume":"59","author":"F Garrido","year":"2010","unstructured":"Garrido F, Algarra I, Garc\u00eda-Lora AM (2010) The escape of cancer from T lymphocytes: immunoselection of MHC class I loss variants harboring structural-irreversible \u201chard\u201d lesions. Cancer Immunol Immunother 59(10):1601\u20131606","journal-title":"Cancer Immunol Immunother"},{"issue":"4","key":"1121_CR19","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.4049\/jimmunol.175.4.2144","volume":"175","author":"B Rincon-Orozco","year":"2005","unstructured":"Rincon-Orozco B, Kunzmann V, Wrobel P, Kabelitz D, Steinle A, Herrmann T (2005) Activation of V gamma 9V delta 2 T cells by NKG2D. J Immunol 175(4):2144\u20132151","journal-title":"J Immunol"},{"issue":"4","key":"1121_CR20","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1002\/eji.1830270422","volume":"27","author":"D Wesch","year":"1997","unstructured":"Wesch D, Marx S, Kabelitz D (1997) Comparative analysis of alpha beta and gamma delta T cell activation by Mycobacterium tuberculosis and isopentenyl pyrophosphate. Eur J Immunol 27(4):952\u2013956","journal-title":"Eur J Immunol"},{"issue":"1","key":"1121_CR21","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1128\/IAI.66.1.98-106.1998","volume":"66","author":"KN Balaji","year":"1998","unstructured":"Balaji KN, Boom WH (1998) Processing of Mycobacterium tuberculosis bacilli by human monocytes for CD4+ alphabeta and gammadelta T cells: role of particulate antigen. Infect Immun 66(1):98\u2013106","journal-title":"Infect Immun"},{"issue":"5","key":"1121_CR22","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.4049\/jimmunol.179.5.3057","volume":"179","author":"A Martino","year":"2007","unstructured":"Martino A, Casetti R, Sacchi A, Poccia F (2007) Central memory Vgamma9Vdelta2 T lymphocytes primed and expanded by bacillus Calmette-Gu\u00e9rin-infected dendritic cells kill mycobacterial-infected monocytes. J Immunol 179(5):3057\u20133064","journal-title":"J Immunol"},{"issue":"11","key":"1121_CR23","doi-asserted-by":"crossref","first-page":"5832","DOI":"10.4049\/jimmunol.154.11.5832","volume":"154","author":"MJ Skeen","year":"1995","unstructured":"Skeen MJ, Ziegler HK (1995) Activation of gamma delta T cells for production of IFN-gamma is mediated by bacteria via macrophage-derived cytokines IL-1 and IL-12. J Immunol 154(11):5832\u20135841","journal-title":"J Immunol"},{"issue":"12","key":"1121_CR24","doi-asserted-by":"crossref","first-page":"3066","DOI":"10.1002\/eji.1830261237","volume":"26","author":"C Ueta","year":"1996","unstructured":"Ueta C, Kawasumi H, Fujiwara H, Miyagawa T, Kida H, Ohmoto Y, Kishimoto S, Tsuyuguchi I (1996) Interleukin-12 activates human gamma delta T cells: synergistic effect of tumor necrosis factor-alpha. Eur J Immunol 26(12):3066\u20133073","journal-title":"Eur J Immunol"},{"issue":"11","key":"1121_CR25","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1002\/eji.200425368","volume":"34","author":"F Dieli","year":"2004","unstructured":"Dieli F, Caccamo N, Meraviglia S, Ivanyi J, Sireci G, Bonanno CT, Ferlazzo V, La Mendola C, Salerno A (2004) Reciprocal stimulation of gammadelta T cells and dendritic cells during the anti-mycobacterial immune response. Eur J Immunol 34(11):3227\u20133235","journal-title":"Eur J Immunol"},{"issue":"16","key":"1121_CR26","doi-asserted-by":"crossref","first-page":"e74","DOI":"10.1182\/blood-2010-02-258558","volume":"116","author":"L Ziegler-Heitbrock","year":"2010","unstructured":"Ziegler-Heitbrock L, Ancuta P, Crowe S, Dalod M, Grau V, Hart DN, Leenen PJ, Liu YJ, MacPherson G, Randolph GJ, Scherberich J, Schmitz J, Shortman K, Sozzani S, Strobl H, Zembala M, Austyn JM, Lutz MB (2010) Nomenclature of monocytes and dendritic cells in blood. Blood 116(16):e74\u2013e80","journal-title":"Blood"},{"issue":"2\u20133","key":"1121_CR27","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0169-5002(01)00210-0","volume":"33","author":"JM Wroblewski","year":"2001","unstructured":"Wroblewski JM, Bixby DL, Borowski C, Yannelli JR (2001) Characterization of human non-small cell lung cancer (NSCLC) cell lines for expression of MHC, co-stimulatory molecules and tumor-associated antigens. Lung Cancer 33(2\u20133):181\u2013194","journal-title":"Lung Cancer"},{"issue":"4","key":"1121_CR28","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1182\/blood.V98.4.1108","volume":"98","author":"K Hallermalm","year":"2001","unstructured":"Hallermalm K, Seki K, Wei C, Castelli C, Rivoltini L, Kiessling R, Levitskaya J (2001) Tumor necrosis factor-alpha induces coordinated changes in major histocompatibility class I presentation pathway, resulting in increased stability of class I complexes at the cell surface. Blood 98(4):1108\u20131115","journal-title":"Blood"},{"key":"1121_CR29","unstructured":"Dormond O, Lejeune FJ, Ruegg C (2002) Modulation of cdk2, cyclin D1, p16INK4a, p21WAF and p27Kip1 expression in endothelial cells by TNF\/IFN gamma. Anticancer Res 22(6A):3159\u20133163"},{"issue":"26","key":"1121_CR30","doi-asserted-by":"crossref","first-page":"3670","DOI":"10.1038\/sj.onc.1209402","volume":"25","author":"CE Egwuagu","year":"2006","unstructured":"Egwuagu CE, Li W, Yu CR, Che Mei Lin M, Chan CC, Nakamura T, Chepelinsky AB (2006) Interferon-gamma induces regression of epithelial cell carcinoma: critical roles of IRF-1 and ICSBP transcription factors. Oncogene 25(26):3670\u20133679","journal-title":"Oncogene"},{"issue":"4","key":"1121_CR31","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.4049\/jimmunol.157.4.1350","volume":"157","author":"LM Bradley","year":"1996","unstructured":"Bradley LM, Dalton DK, Croft M (1996) A direct role for IFN-gamma in regulation of Th1 cell development. J Immunol 157(4):1350\u20131358","journal-title":"J Immunol"},{"issue":"7","key":"1121_CR32","doi-asserted-by":"crossref","first-page":"3645","DOI":"10.4049\/jimmunol.164.7.3645","volume":"164","author":"A Pr\u00e9vost-Blondel","year":"2000","unstructured":"Pr\u00e9vost-Blondel A, Roth E, Rosenthal FM, Pircher H (2000) Crucial role of TNF-alpha in CD8 T cell-mediated elimination of 3LL-A9 Lewis lung carcinoma cells in vivo. J Immunol 164(7):3645\u20133651","journal-title":"J Immunol"},{"issue":"4","key":"1121_CR33","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1046\/j.1365-2567.2001.01279.x","volume":"103","author":"N Seo","year":"2001","unstructured":"Seo N, Hayakawa S, Takigawa M, Tokura Y (2001) Interleukin-10 expressed at early tumour sites induces subsequent generation of CD4(+) T-regulatory cells and systemic collapse of antitumour immunity. Immunology 103(4):449\u2013457","journal-title":"Immunology"},{"issue":"11","key":"1121_CR34","doi-asserted-by":"crossref","first-page":"7287","DOI":"10.4049\/jimmunol.0804288","volume":"182","author":"M Todaro","year":"2009","unstructured":"Todaro M, D\u2019Asaro M, Caccamo N, Iovino F, Francipane MG, Meraviglia S, Orlando V, La Mendola C, Gulotta G, Salerno A, Dieli F, Stassi G (2009) Efficient killing of human colon cancer stem cells by gammadelta T lymphocytes. J Immunol 182(11):7287\u20137296","journal-title":"J Immunol"},{"issue":"13","key":"1121_CR35","doi-asserted-by":"crossref","first-page":"4232","DOI":"10.1158\/1078-0432.CCR-07-4912","volume":"14","author":"AA Alexander","year":"2008","unstructured":"Alexander AA, Maniar A, Cummings JS, Hebbeler AM, Schulze DH, Gastman BR, Pauza CD, Strome SE, Chapoval AI (2008) Isopentenyl pyrophosphate-activated CD56+ \u03b3\u03b4 T lymphocytes display potent antitumor activity toward human squamous cell carcinoma. Clin Cancer Res 14(13):4232\u20134240","journal-title":"Clin Cancer Res"},{"issue":"8","key":"1121_CR36","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1007\/s00262-007-0279-2","volume":"56","author":"SR Mattarollo","year":"2007","unstructured":"Mattarollo SR, Kenna T, Nieda M, Nicol AJ (2007) Chemotherapy and zoledronate sensitize solid tumour cells to Vgamma9Vdelta2 T cell cytotoxicity. Cancer Immunol Immunother 56(8):1285\u20131297","journal-title":"Cancer Immunol Immunother"},{"issue":"1","key":"1121_CR37","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1182\/blood-2002-12-3665","volume":"102","author":"M Wilhelm","year":"2003","unstructured":"Wilhelm M, Kunzmann V, Eckstein S, Reimer P, Weissinger F, Ruediger T, Tony HP (2003) Gammadelta T cells for immune therapy of patients with lymphoid malignancies. Blood 102(1):200\u2013206","journal-title":"Blood"},{"issue":"15","key":"1121_CR38","doi-asserted-by":"crossref","first-page":"7450","DOI":"10.1158\/0008-5472.CAN-07-0199","volume":"67","author":"F Dieli","year":"2007","unstructured":"Dieli F, Vermijlen D, Fulfaro F, Caccamo N, Meraviglia S, Cicero G, Roberts A, Buccheri S, D\u2019Asaro M, Gebbia N, Salerno A, Eberl M, Hayday AC (2007) Targeting human \u03b3\u03b4 T cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancer. Cancer Res 67(15):7450\u20137457","journal-title":"Cancer Res"},{"issue":"1","key":"1121_CR39","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00262-008-0521-6","volume":"58","author":"D Santini","year":"2009","unstructured":"Santini D, Martini F, Fratto ME, Galluzzo S, Vincenzi B, Agrati C, Turchi F, Piacentini P, Rocci L, Manavalan JS, Tonini G, Poccia F (2009) In vivo effects of zoledronic acid on peripheral gammadelta T lymphocytes in early breast cancer patients. Cancer Immunol Immunother 58(1):31\u201338","journal-title":"Cancer Immunol Immunother"},{"key":"1121_CR40","doi-asserted-by":"crossref","first-page":"219","DOI":"10.2147\/TCRM.S7245","volume":"6","author":"EC Serefoglu","year":"2010","unstructured":"Serefoglu EC, Tandogdu Z (2010) Efficacy and safety of zoledronic acid in the treatment of glucocorticoid-induced osteoporosis. Ther Clin Risk Manag 6:219\u2013223","journal-title":"Ther Clin Risk Manag"},{"issue":"9","key":"1121_CR41","doi-asserted-by":"crossref","first-page":"5508","DOI":"10.4049\/jimmunol.166.9.5508","volume":"166","author":"F Miyagawa","year":"2001","unstructured":"Miyagawa F, Tanaka Y, Yamashita S, Minato N (2001) Essential requirement of antigen presentation by monocyte lineage cells for the activation of primary human gamma delta T cells by aminobisphosphonate antigen. J Immunol 166(9):5508\u20135514","journal-title":"J Immunol"},{"issue":"7","key":"1121_CR42","doi-asserted-by":"crossref","first-page":"4798","DOI":"10.4049\/jimmunol.181.7.4798","volume":"181","author":"H Wei","year":"2008","unstructured":"Wei H, Huang D, Lai X, Chen M, Zhong W, Wang R, Chen ZW (2008) Definition of APC presentation of phosphoantigen (E)-4-hydroxy-3-methyl-but-2-enyl pyrophosphate to Vgamma2Vdelta 2 TCR. J Immunol 181(7):4798\u20134806","journal-title":"J Immunol"},{"issue":"8","key":"1121_CR43","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1002\/eji.200838366","volume":"38","author":"M Kistowska","year":"2008","unstructured":"Kistowska M, Rossy E, Sansano S, Gober HJ, Landmann R, Mori L, De Libero G (2008) Dysregulation of the host mevalonate pathway during early bacterial infection activates human TCR gamma delta cells. Eur J Immunol 38(8):2200\u20132209","journal-title":"Eur J Immunol"},{"issue":"4","key":"1121_CR44","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S1074-7613(00)00045-5","volume":"13","author":"O Schulz","year":"2000","unstructured":"Schulz O, Edwards AD, Schito M, Aliberti J, Manickasingham S, Sher A, Reis e Sousa C (2000) CD40 triggering of heterodimeric IL-12 p70 production by dendritic cells in vivo requires a microbial priming signal. Immunity 13(4):453\u2013462","journal-title":"Immunity"},{"issue":"5","key":"1121_CR45","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1002\/(SICI)1521-4141(200005)30:5<1512::AID-IMMU1512>3.0.CO;2-3","volume":"30","author":"F Dieli","year":"2000","unstructured":"Dieli F, Troye-Blomberg M, Ivanyi J, Fourni\u00e9 JJ, Bonneville M, Peyrat MA, Sireci G, Salerno A (2000) Vgamma9\/Vdelta2 T lymphocytes reduce the viability of intracellular Mycobacterium tuberculosis. Eur J Immunol 30(5):1512\u20131519","journal-title":"Eur J Immunol"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/s00262-011-1121-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,10]],"date-time":"2023-06-10T13:14:56Z","timestamp":1686402896000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00262-011-1121-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10,15]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["1121"],"URL":"https:\/\/doi.org\/10.1007\/s00262-011-1121-4","relation":{},"ISSN":["0340-7004","1432-0851"],"issn-type":[{"value":"0340-7004","type":"print"},{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,10,15]]}}}